Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“There are 10 total tests that make up the company’s “release testing.” To date, 5 of those 10 tests have been completed and all 5 have passed, including 4 of the 5 tests being conducted by third-party laboratories on the first manufactured batch of PharmaCyte’s clinical trial product.”
My thoughts are that they are waiting on the mycoplasma test from Eurofins and the four remaining functionality tests from austrianova. I believe we are looking at 4-6 weeks each run from start of testing to COA issuance.
Some of those tests are done quickly which is why I think we will hear run 2 partial results along with run 1 COA. Hope you do well with this Pete you’ve been in a long time.
The tests will take the same amount of time- they’re standardized tests. I feel like we’ll be ready to file either just before or possibly just after Christmas. Jmo
I think everything is going just as it should and expect another pr next week with possibility of run 1 released and partial run 2 results. I agree with Pink - patience is all we need now. Glta
Happy Thanksgiving everyone!
Don’t give up on the last mile Pete.
I think we’ll file once both clinical batches have been released with a COA. Hope you make money you’ve been a loyal long for years.
Won’t take that long once the platform is validated by pc clinical results. And then a major player can fast track the diabetes trials. Sorry about your losses Pete.
Stem cell or encapsulated beta eyelet or any cell line discovery producing insulin. We have those rights worldwide.
The global diabetes drugs market is expected to reach USD 94 billion by 2023 at a CAGR of 5.65%, during the forecast period.
https://www.marketwatch.com/press-release/diabetes-drug-intelligence-center-2019-global-database-with-coverage-through-2012-2023---insulin-holds-the-highest-market-share-and-sanofi-novo-nordisk-and-eli-lilly-dominate---researchandmarketscom-2019-03-20
Golden - What does that mean for shareholders?
sterility - 14 days
endotoxin - same day test
pH - simple read minutes mycoplasma- up to 28 days
cell identity - not sure but believe there is an automated system to do this.
Pyrogenicity - if same as used to be is injected in rabbits- guessing a week
Not sure but also think it’s reasonable for Ken to use the planned December CC to announce IND filing.
Thanks rayla! Much appreciated.
Sterility testing is 14 days
Sorry for the typo - that was “opinion”
Depends on the time required for release testing of the batches- longest I’ve personally seen is a month- so I am expecting between November and end of year - but without insight to the testing involved is just an option. Good luck to you also A2z.
I’ve seen the picture and it is typical of the isolator set up - you have a class 7 or grade C room that you wear the usual clean room gowning to enter and the isolator has suits and or gloves people work through without ever entering- the isolator is a class 5 or grade A area that is always positive pressure to the room it’s assembled in. Good luck bear.
I would have to listen again but the three weeks sounds like testing to release the isolator initially- between batches would be a peroxide based fumigation- much shorter - and none of those cleaners such as pine sol are even allowed in a clean room let alone an isolator- hang in there tulla and very good luck to you!
agree. Everything I heard was very consistent with my experience in the GMP business- I’m good and will not be selling a single share.
I don’t know any more about what’s happening behind the scenes than anyone else here, but I worked for a Fortune 500 bio that never released PRs until after the market closed. Let’s all hope that is the case here. Good luck everyone.
Link previously posted is the current quarterly report just filed.
Sorry to see you go Brian. Hope you can get back in to reap a much deserved reward down the road.
Agree!
I don’t have 3m shares but agree and am also voting yes. Thanks CA.
Mass Megawatts (OTC:MMMW) Introduces a New Retrofit Option for its Solar Tracker
WORCESTER, Mass., August 26, 2019 — Mass Megawatts Wind Power Inc. (OTC:MMMW) announces an option for purchasers of solar equipment who would like to have the benefits of the cost saving related to the new solar trackers at some point in the future. The customers can use conventional solar equipment placed in service before the new technology is ready for production with minor modifications in its ballast mounts and racking system. At a future date, those solar power projects would have the ability to add solar tracking infrastructure with a minimal amount of effort.
A description of the process and advantages will be available on our website www.massmegawatts.com with a video soon. The website currently has a preliminary prototype video that will be replaced and updated soon with a good for manufacture prototype.
Mass Megawatts is using a new Solar Tracking technology with more electric cost savings for its customers in comparison to stationary solar units without trackers. The patented pending, Mass Megawatts ‘Solar Tracking System’ (STS) is designed to improve solar-energy production while and at the same time reduce material and installation costs. The solar trackers units would cost less than 10 percent more on a given solar project while producing 25 percent more electricity.
The patented pending, Mass Megawatts ‘Solar Tracking System’ (STS) is designed to automatically adjust the position of solar panels throughout the day to receive an optimal-level of direct sunlight. Unlike other solar tracking technologies, the Mass Megawatts STS utilizes a low-cost structure that adds stability to the overall system while also improving energy production levels. The STS also uses a proprietary mechanical innovation to limit dynamic and static loading on the tracker, which can occur during periods of high wind and extreme weather, in order to reduce wind-related stresses and system downtime. The STS allows Mass Megawatts to lower material costs and reduce the number of solar panels needed to generate the rated capacity. Due to this advantage, Mass Megawatts can deliver more solar power production at a price similar to lower-capacity, stationary systems.
Product information and sales inquiries can be made through the company’s contact page at www.massmegawatts.com and the e-mail address on the web site.
This press release contains forward-looking statements that could be affected by risks and uncertainties. Among the factors that could cause actual events to differ materially from those indicated herein are: the failure of Mass Megawatts Wind Power, also known as Mass Megawatts Windpower, to achieve or maintain necessary zoning approvals with respect to the location of its power developments; the ability to remain competitive; to finance the marketing and sales of its electricity; general economic conditions; and other risk factors detailed in periodic reports filed by Mass Megawatts Wind Power.
Contact:
Mass Megawatts Wind Power, Inc.
info@massmegawatts.com www.massmegawatts.com
Pete would love to hear your thoughts on the upcoming vote. Tia
I understand the concern- hopefully we get a few PRs before the meeting to clarify.....
I’m not a financial professional- and can’t predict board motives but hoping they are just trying to protect the company and us because they’re making a big milestone announcement soon.
I feel like the company is trying to avoid a low ball tender offer to acquire a majority of shares from shareholders - once they acquire the majority they get control of the company for way below anticipated value. Jmo
RC hope this helps....
https://www.biryuklaw.com/hostile-takeover-defenses/
Quickly read through that section as well and thought the same. Poison pill to avoid hostile takeovers.
Amen 1234.... longs keep the faith. Still hold every share.
Well said 1234!
In a nutshell yes. Holding every share I’ve ever bought. I believe in this to be a medical game changer.
Agree!
Agree